Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Current Assets (2021 - 2025)

Historic Current Assets for Rxo (RXO) over the last 5 years, with Q4 2025 value amounting to $1.3 billion.

  • Rxo's Current Assets fell 164.3% to $1.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.3 billion, marking a year-over-year decrease of 164.3%. This contributed to the annual value of $1.3 billion for FY2025, which is 164.3% down from last year.
  • Latest data reveals that Rxo reported Current Assets of $1.3 billion as of Q4 2025, which was down 164.3% from $1.2 billion recorded in Q3 2025.
  • In the past 5 years, Rxo's Current Assets registered a high of $1.3 billion during Q4 2024, and its lowest value of $770.0 million during Q1 2024.
  • In the last 5 years, Rxo's Current Assets had a median value of $1.1 billion in 2021 and averaged $1.1 billion.
  • Data for Rxo's Current Assets shows a peak YoY increase of 6821.61% (in 2024) and a maximum YoY decrease of 2517.01% (in 2024) over the last 5 years.
  • Over the past 5 years, Rxo's Current Assets (Quarter) stood at $1.1 billion in 2021, then fell by 4.99% to $1.0 billion in 2022, then dropped by 22.64% to $796.0 million in 2023, then soared by 68.22% to $1.3 billion in 2024, then fell by 1.64% to $1.3 billion in 2025.
  • Its last three reported values are $1.3 billion in Q4 2025, $1.2 billion for Q3 2025, and $1.2 billion during Q2 2025.